ChemicalBook > CAS DataBase List > TD 139

TD 139

Product Name
TD 139
CAS No.
1450824-22-2
Chemical Name
TD 139
Synonyms
33DFTG;TD 139;CS-2525;TD-139; TD 139;Olitigaltin (TD-139);3,3'-dideoxy-3,3'-di-[4-(3-fluorophenyl)-1H-1,2,3-triazol-1-yl]-1,1'-surfanediyl-di-D-galactopyranoside;(2R,2'R,3R,3'R,4S,4'S,5R,5'R,6S,6'S)-6,6'-Thiobis(4-(4-(3-fluorophenyl)-1H-1,2,3-triazol-1-yl)-2-(hydroxymethyl)tetrahydro-2H-pyran-3,5-diol);β-D-Galactopyranoside, 3-deoxy-3-[4-(3-fluorophenyl)-1H-1,2,3-triazol-1-yl]-β-D-galactopyranosyl 3-deoxy-3-[4-(3-fluorophenyl)-1H-1,2,3-triazol-1-yl]-1-thio-
CBNumber
CB73167095
Molecular Formula
C28H30F2N6O8S
Formula Weight
648.64
MOL File
1450824-22-2.mol
More
Less

TD 139 Property

Boiling point:
1017.2±75.0 °C(Predicted)
Density 
1.76±0.1 g/cm3(Predicted)
pka
12.33±0.70(Predicted)
form 
Solid
color 
White to off-white
InChIKey
YGIDGBAHDZEYMT-YNKUJGNYNA-N
More
Less

Hazard and Precautionary Statements (GHS)

More
Less

N-Bromosuccinimide Price

Cayman Chemical
Product number
28400
Product name
TD139
Packaging
1mg
Price
$80
Updated
2021/12/16
Cayman Chemical
Product number
28400
Product name
TD139
Packaging
10mg
Price
$640
Updated
2021/12/16
Cayman Chemical
Product number
28400
Product name
TD139
Packaging
5mg
Price
$360
Updated
2021/12/16
Biosynth Carbosynth
Product number
BT173009
Product name
TD 139
Packaging
10mg
Price
$125
Updated
2021/12/16
Biosynth Carbosynth
Product number
BT173009
Product name
TD 139
Packaging
25mg
Price
$250
Updated
2021/12/16
More
Less

TD 139 Chemical Properties,Usage,Production

Uses

TD 139 is used as a galactoside inhibitors of galectins, suitable for treating pulmonary fibrosis; such as idiopathic pulmonary fibrosis in mammals.

Synthesis

1193784-39-2

2561-17-3

1450824-22-2

Bis-(3-azido-3-deoxy-β-D-galactopyranosyl)-thiane (11) and 3-fluorophenylacetylene (3 eq.) were synthesized by cycloaddition reaction in the presence of a Cu(I) catalyst (0.2 eq.) and triethylamine (2 eq.) in N,N-dimethylformamide (DMF, 100 mL/mmol of thiane) under room temperature conditions TD139.The progress of the reaction was monitored by thin layer chromatography (TLC) until completion. After the reaction mixture was concentrated, it was first initially purified by fast column chromatography (eluent: CH2Cl2:MeOH, 8:1), followed by final purification by preparative high-performance liquid chromatography (HPLC) to afford TD139 in 76% yield as a white amorphous solid.1H-NMR (CD3OD, 400 MHz) δ 8.59 (s, 2H, triazole-H ), 7.63 (br d, 2H, J = 7.6 Hz, Ar-H), 7.57 (br d, 2H, J = 8.4 Hz, Ar-H), 7.41 (dt, 2H, J = 6.0, 8.0 Hz, Ar-H), 7.05 (br dt, 2H, J = 2.4, 6.4 Hz, Ar-H), 4.93 (dd, 2H, J = 2.4 , 10.4 Hz, H3), 4.92 (d, 2H, J = 10.4 Hz, H1), 4.84 (d, 2H, J = 10.4 Hz, H2), 4.18 (d, 2H, J = 2.4 Hz, H4), 3.92 (dd, 2H, J = 4.2, 7.6 Hz, H5), 3.84 (dd, 2H, J = 7.6, 11.4 Hz , H6), 3.73 (dd, 2H, J = 4.2, 11.4 Hz, H6); the FAB-HRMS m/z calculated value of C28H30F2N6NaO8S (M + Na+) was 671.1712 and the measured value was 671.1705.

in vivo

In primary lung AECs TD139 reduces TGF-β1–induced β-catenin translocation to the nucleus, with most of the β-catenin remaining at the cell surface. TD139 blocks TGF-β1–induced β-catenin phosphorylation. A marked reduction in fibrosis and β-catenin activation accompanied by decreased galectin-3 expression is observed in the lungs of WT mice treated with TD139[1]. Pretreatment of WT C57BL/6 mice with TD139 leads to the attenuation of liver injury and milder infiltration of IFNγ- and IL-17- and -4-producing CD4(+) T cells, as well as an increase in the total number of IL-10-producing CD4(+) T cells and F4/80(+) CD206(+) alternatively activates macrophages and preventes the apoptosis of liver-infiltrating MNCs[2].

References

[1] Patent: US2014/121179, 2014, A1. Location in patent: Paragraph 0188; 0200
[2] Patent: WO2014/78655, 2014, A1. Location in patent: Page/Page column 90; 94
[3] ChemBioChem, 2016, vol. 17, # 18, p. 1759 - 1770

TD 139 Preparation Products And Raw materials

Raw materials

Preparation Products

More
Less

TD 139 Suppliers

Nantong QuanYi Biotechnology Co., Ltd
Tel
0513-66337626 18051384581
Email
sales@chemhifuture.com
Country
China
ProdList
5929
Advantage
58
MedChemexpress LLC
Tel
021-58955995
Fax
609-228-5909
Email
sales@medchemexpress.cn
Country
United States
ProdList
4861
Advantage
58
ShangHai Caerulum Pharma Discovery Co., Ltd.
Tel
18149758185
Email
sales-cpd@caerulumpharma.com
Country
China
ProdList
3506
Advantage
58
Shanghai Lollane Biological Technology Co.,Ltd.
Tel
021-52996696,15000506266 15000506266
Fax
+86-21-52996696
Country
China
ProdList
4757
Advantage
55
Shanghai EFE Biological Technology Co., Ltd.
Tel
021-65675885 18964387627
Fax
021-65675885
Email
info@efebio.com
Country
China
ProdList
9803
Advantage
58
Shanghai YuanYe Biotechnology Co., Ltd.
Tel
021-61312847; 18021002903
Fax
QQ:3008007432
Email
3008007409@qq.com
Country
China
ProdList
71826
Advantage
60
Amadis Chemical Company Limited
Tel
571-89925085
Fax
0086-571-89925065
Email
sales@amadischem.com
Country
China
ProdList
131957
Advantage
58
Twochem Co.Ltd.
Tel
021-58111628 15800915896
Fax
QQ 3285589261
Email
sales@twochem.com
Country
China
ProdList
1788
Advantage
58
Tianjin Kaifu Pharmaceutical Technology Co., Ltd.
Tel
18081075745
Email
chemflowtech@sina.com
Country
China
ProdList
1886
Advantage
58
TargetMol Chemicals Inc.
Tel
+1-781-999-5354; +17819995354
Email
marketing@targetmol.com
Country
United States
ProdList
32435
Advantage
58

1450824-22-2, TD 139Related Search:


  • TD 139
  • 3,3'-dideoxy-3,3'-di-[4-(3-fluorophenyl)-1H-1,2,3-triazol-1-yl]-1,1'-surfanediyl-di-D-galactopyranoside
  • CS-2525
  • TD-139; TD 139
  • β-D-Galactopyranoside, 3-deoxy-3-[4-(3-fluorophenyl)-1H-1,2,3-triazol-1-yl]-β-D-galactopyranosyl 3-deoxy-3-[4-(3-fluorophenyl)-1H-1,2,3-triazol-1-yl]-1-thio-
  • (2R,2'R,3R,3'R,4S,4'S,5R,5'R,6S,6'S)-6,6'-Thiobis(4-(4-(3-fluorophenyl)-1H-1,2,3-triazol-1-yl)-2-(hydroxymethyl)tetrahydro-2H-pyran-3,5-diol)
  • 33DFTG
  • Olitigaltin (TD-139)
  • 1450824-22-2
  • C28H30F2N6O8S